Health Care Roundup: Market Talk
Find insight on AstraZeneca, Novartis, GSK and more in the latest Market Talks covering Health Care. Source link
Health
Americans born after 1970 face higher death rates from several major causes in middle age
NEWYou can now listen to Fox News articles! Americans born after 1970 are dying faster than their parents did, data
Apotex Shares Rally as Trading Begins Following Pricing of C$1.3 Billion IPO
The company’s shares opened 17% above the offering price before cooling slightly, marking Canada’s biggest initial public offering in years.
Dirty soda drinks are everywhere, but doctors warn of health risks: ‘Metabolic disaster’
NEWYou can now listen to Fox News articles! The latest beverage trend is far from clean – and it’s raising
Johnson & Johnson CEO Says Cure for Certain Cancers Is Realistic Goal
Joaquin Duato said AI was already helping the company develop medicines faster, but the extent to which it boosts its
Sanofi to Stop Late-Stage Study of Immune-Disorder Drug
The termination is an early setback to new chief executive Belen Garijo, who took the helm last month. Source link
After shedding its cancer business just over a decade ago, GSK’s new CEO is building back with a $10.6 billion deal
After shedding its oncology business just over a decade ago, GSK is building it back with a $10.6 billion deal.
You’ve never heard of it, but you very well may have it. Medical bodies develop the first guidelines to treat cardiovascular-kidney-metabolic syndrome, which likely affects 90% of Americans.
Nearly 90% of Americans meet the criteria for CKM syndrome. New guidelines have been issued for diagnosing and treating the
Diabetes drug could slash risk of fatal heart condition in one group, scientists reveal
NEWYou can now listen to Fox News articles! A diabetes drug could help lower the risk of heart failure in
Health Care Roundup: Market Talk
Find insight on GSK’s $10.6 billion acquisition of Nuvalent, AstraZeneca and more in the latest Market Talks covering Health Care.